Browsing Tag
Gisela Mautner
2 posts
Noxopharm bags new funding to fuel game-changing cancer treatments
Noxopharm Limited, an Australian biotech powerhouse, has successfully raised A$2.1 million in funding through the issuance of convertible…
Noxopharm’s Veyonda shows potential in treating severe COVID-19 symptoms in Phase 1 trial
Australian drug development company Noxopharm has embarked on an important milestone in the fight against COVID-19. The company…